Regenerative medicine and liver injury: What role for bone marrow derived stem cells?

Current Stem Cell Research and Therapy

Volumn 2, Issue 1, 2007, Pages 83-88

  Lorenzini, Stefania ^a   Andreone, Pietro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Adult stem cells; Bone marrow; Cell fusion; Liver regeneration; Transdifferentiation

Indexed keywords

BONE MARROW CELL; BYSTANDER EFFECT; CELL DIFFERENTIATION; CELL FUSION; CELL POPULATION; CELL TYPE; HEMATOPOIETIC STEM CELL; HUMAN; HYPOTHESIS; LIVER DISEASE; LIVER INJURY; LIVER REGENERATION; NONHUMAN; PLANNING; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TISSUE REPAIR;

ANIMALS; BONE MARROW CELLS; HEPATOCYTES; HUMANS; LIVER DISEASES; REGENERATIVE MEDICINE; STEM CELLS;

EID: 34248211350     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488807779317026     Document Type: Review

References (49)

1. Taub R. Liver Regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004; 5: 836-47.
2. Higgins GM, Anderson RM. Experimental pathology of the liver. Restoration of the liver of the white rat following white rat partial surgical removal. Arch Pathol 1931; 12: 186-202.
3. Fausto N. Liver regeneration. J Hepatol 2000; 32: 19-31.
4. Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 2004; 6: 1477-87.
5. Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284: 1168-70.
6. Menthena A, Deb N, Oertel M, et al. Bone Marrow Progenitors Are Not the Source of Expanding Oval Cells in Injured Liver. Stem Cells 2004; 22: 1049-61.
7. Wang X, Willenbring H, Akkari Y, et al. Cell fusion is the principal source of bone marrow derived hepatocytes. Nature 2003; 422: 897-901.
8. Yang QL, Nichols J, Evans Ep, Smith AG. Changing potency by spontaneous fusion. Nature 2002; 416: 545-8.
9. Tosh D, Strain A. Liver stem cells - prospects for clinical use. J Hepatol 2005; 42: S75-4.
10. Yamazaki S, Miki K, Hasegawa K, Sata M, Takayama T, Makuuchi M. Sera from liver failure patients and demethylating agent stimulate transdifferentiation of murine bone marrow cells into hepatocytes in coculture with nonparenchymal liver cells. J Hepatol 2003; 39: 17-23.
11. Saji Y, Tamura S, Yoshida Y, et al. Basic fibroblast growth factor promotes the trans-differentiation of mouse bone marrow cells into hepatic lineage cells via multiple liver-enriched transcription factors. J Hepatol 2004; 41: 545-50.
12. Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis Sj. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 2004; 6: 532-9.
13. Yamada Y, Nishimoto E, Mitsuya H, Yonemura Y. In vitro transdifferentiation of adult bone marrow Sca-1+ cKit- cell cocultured with fetal liver cells into hepatic-like cells without fusion. Exp Hematol 2006; 34: 97-106.
14. Jiang YH, Jahagirdar BN, Reinhardt RL, et al. pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-9.
15. Tolar J, O'Shaughnessy MJ, Mortari Panoskaltsis A, et al. Host factors that impact the biodistribution and persistence of multipotent progenitor cells. Blood 2006; [Epub ahead of print].
16. Schwartz RE, Reyes M, Koodie L, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Inv 2002; 169: 1291-301.
17. Lee KD, Kuo TK, Whnag-Peng J, et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004; 40: 1275-84.
18. Tang LJ, Gao Y, Zhang Z, Li H, Shan YQ. Human bone marrow multipotent adult progenitor cells differentiate into hepatocyte-like cells with hepatocyte growth factor plus fibroblast growth factor-4 in vitro. Zhongua Gan Zang Bing Za Zhi 2005; 13: 652-5 (Abstract).
19. Avital I, Inderbitzin D, Aoki T, et al. Isolation, Characterization, and transplantation of bone marrow-derived hepatocyte stem cells. Bioch Bioph Res Comm 2001; 288: 156-64.
20. Inderbitzin D, Avital I, Keogh A, et al. Interleukin-3 induces hepatocyte-specific metabolic activity in bone marrow-derived liver stem cells. J Gastroint Surg 2005; 9: 69-74.
21. Pasquinelli C, Shoenberger JM, Chung J, et al. Hepatitis C virus core and E2 protein expression in transgenic mice. Hepatology 1997; 25: 719-27.
22. Mancini M. Hadchouel M, Tiollais P, Pourcel C, Michel ML. Induction of anti-hepatitis B surface antigen (HbsAg) antibodies in HbsAg producing transgenic mice: a possible way of circumventing "nonresponse" to HbsAg. J Med Virol 1993; 39: 67-74.
23. Grompe M, Al-Dhalimy M, Finegold M, et al. Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Dev 1993; 7: 2298-307.
24. Grompe M, Lindstedt S, Al-Dhalimy M, et al. Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I. Nat Genet 1995; 10: 453-60.
25. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000; 6: 1229-34.
26. Vassilopoulos G, Wang P, Russel DW. Transplanted bone marrow regenerates liver by cell fusion. Nat Med 2003; 422: 901-4.
27. Willenbring H, Bailey A, Foster M, et al. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat Med 2004; 10: 744-8.
28. Wang X, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Grompe M. The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci USA 2003; 100: 11881-8.
29. Parwaresch MR, Kreipe H, Radzun HJ. Human macrophage hybrid forming spontaneous giant cells. Virchows Arch B Cell Pathol Incl Mol Pathol 1986; 51: 89-96.
30. Petersen BE, Zajaz VF, Michalopoulos GK. Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats. Hepatology 1998; 27: 1030-8.
31. Terai S, Sakaida I, Yamamoto N, et al. An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes. J Biochem 2003; 134: 551-8.
32. Yannaki E, Athanasiou E, Xagorari A, et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repairs programs. Exp Hematol 3005; 33: 108-119.
33. Yamamoto N, Terai S, Ohata S, et al. A subpopulation of bone marrow cells depleted by a novel antibody, anti-Liv8, is useful for cell therapy to repair damaged liver. Biochem Biophys Res Communic 2004; 313: 1110-8.
34. 4-induced liver fibrosis in mice. Hepatology 2004; 40: 1304-11.
35. Fang B, Shi M, Liao L, Yang S, Liu Y, Zhao RC. Systemic infusion of FLK1+ mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 2004; 78: 83-8.
36. Zhao DC, Lei JX, Yu W, Zhang X, Li S, Xiang P. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol 2005; 11: 3431-3440.
37. Sato Y, Araki H, Kato J, et al. human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005; 106: 756-63.
38. Luk JM, Wang PP, Lee CK, Wang JH, Fan St. hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models. J Immunol Methods 2005; 35: 39-47.
39. Vig P, Russo FP, Edwards RJ, et al. The source of parenchymal regeneration after chronic hepatocellular liver injury. Hematology 2006; 43: 316-24.
40. Theocharis SE, Agapitos EB, Margeli AP, Goutas ND, Kittas CN, davaris PS. Effect of two forms of granulocyte-colony-stimulating factor on hepatic regeneration after 70% partial hepatectomy in rats. Clin Sci (Lond) 1997; 92: 315-20.
41. Alison MR, Poulsom R, Jeffery R, Dhillon AP, Quaglia A, Jacob J. Hepatocytes from non hepatic adult stem cells. Nature 2000; 406: 257.
42. Körbling M, Katz R, Khanna A, et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med 2002; 346: 738-46.
43. Gehling UM, Willems M, Dandri M, et al. Partial hepatectomy induces mobilization of a unique population of haematopoietic progenitor cells in human healthy liver donors. J Hepatol 2005; 43: 845-53.
44. Di Campli C, Piscaglia AC, Giuliante F, et al. No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure. Transpl Proc 2005; 37: 2563-6.
45. Yu I, Flint A, Dvorin EL, Bischoff J. AC133-2, a novel isoform of human AC133 stem cell antigen. J Biochem 2002; 277: 20711-6.
46. am Esch JS 2nd, Knoefel WT, Klein M, et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 2005: 23: 463-70.
47. Gordon MY, Levicar N, Pai M, et al. characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by G-CSF. Stem Cells 2006; [Epub ahead of print].
48. Thiese ND. Emergent themes of liver stem cell biology: niche, quiescence, self-renewal, and plasticity. Am J Physiol Gastrointest Liver Physiol 2006; 290: 189-93.
49. Allen KJ, Buck NE, Williamson R. Stem cells for the treatment of liver disease. Transpl Immunol 2005; 15: 99-112.